Old Web
English
Sign In
Acemap
>
authorDetail
>
N. Nazarenko
N. Nazarenko
Ipsen
Cancer research
Medicine
Platinum
Liposomal Irinotecan
non small cell
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
MO01.39 Liposomal Irinotecan in Adults with Small Cell Lung Cancer who Progressed on Platinum-Based Therapy: Subgroup Analyses by Platinum Sensitivity
2021
Journal of Thoracic Oncology
David R. Spigel
Luis Paz-Ares
Yuanbin Chen
Maria Jove
O. Juan-Vidal
Patricia Rich
T. Hayes
V.G. Calderón
R.B. Caro
Atilio Navarro
Afshin Dowlati
Bin Zhang
Yan Moore
T. Wang
N. Nazarenko
Jaba Kokhreidze
Santiago Ponce
Paul A. Bunn
Show All
Source
Cite
Save
Citations (0)
First-in-human biomarker-driven phase I trial of the potent and selective glutaminase-1 (GLS1) inhibitor IACS-6274 (IPN60090) in patients (pts) with molecularly selected advanced solid tumors.
2021
Journal of Clinical Oncology
Timothy A. Yap
Ecaterina Elena Dumbrava
Jordi Rodon Ahnert
David S. Hong
Shubham Pant
Daniel D. Karp
Sarina Anne Piha-Paul
Vivek Subbiah
Apostolia Maria Tsimberidou
Siqing Fu
Filip Janku
Sandra Montez
Majd T Ahmad-Taha
Darlene Guerrero
N. Nazarenko
Y. Moore
Michael J Soth
Jeff Kovacs
Timothy P. Heffernan
Philip Jones
Show All
Source
Cite
Save
Citations (0)
1
map